Inozyme Pharma, Inc. (NASDAQ:INZY) Receives $17.00 Average Price Target from Analysts
Inozyme Pharma, Inc. (NASDAQ:INZY – Get Free Report) has been assigned a consensus rating of “Buy” from the eight ratings firms that are presently covering the stock, MarketBeat reports. Eight investment analysts have rated the stock with a buy rating. The average 12-month target price among brokers that have updated their coverage on the stock […]
More Stories
Sakamoto Days Season 2: Release Date, Trailer, and Where to Watch?
Sakamoto Days, the 2025 series, is coming back! For Sakamoto Days fans, the blend of action, comedy, and adventure is...
Is Blue Eye Samurai Season 2 Announced? Release Date, Trailer, and More
Netflix’s adult anime series, Blue Eye Samurai, first premiered in 2023 and has quickly become one of the most acclaimed...
Oasis Season 1 is Live on Netflix! Review, Rating, and Update on Season 2 Release
Netflix has released an all-new Spanish mystery thriller, Oasis, season 1. The series is full of thriller scenes and suspenseful...
Ricky Gervais’ Alley Cats Trailer is Out! Know the Release Date and Other Details
Ricky Gervais is coming back with an all-new adult animated series, Alley Cats. The theme is about the everyday life...
Better Late Than Single Season 2: Release Date, Contestants Details, Trailer, and More
Better Late Than Single is a South Korean reality show that first premiered on Netflix in July 2025. Better Late...
10 Best Animated Movies that You Can Binge-Watch on Netflix
Are you also an animation movie lover, just like me? Here, in this blog, I have mentioned some of the...